# China NMPA Inspection - Guilin Gaole Pharmaceutical and Health Products Co., Ltd. - April 18, 2019

Source: https://www.globalkeysolutions.net/records/china_inspection/guilin-gaole-pharmaceutical-and-health-products-co-ltd/420f5952-299e-40c2-ad5d-0a959950725b/
Source feed: China

> China NMPA unannounced inspection for Guilin Gaole Pharmaceutical and Health Products Co., Ltd. published April 18, 2019. The Guangxi Zhuang Autonomous Region Drug Administration, a Chinese regulatory body, conducted unannounced inspections of several licensed cosmetics m

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Announcement of the Results of Supervision and Inspection of Cosmetic Manufacturers in Guangxi Zhuang Autonomous Region (Issue 1, 2019)
- Company Name: Guilin Gaole Pharmaceutical and Health Products Co., Ltd.
- Publication Date: 2019-04-18
- Product Type: Cosmetics
- Summary: The Guangxi Zhuang Autonomous Region Drug Administration, a Chinese regulatory body, conducted unannounced inspections of several licensed cosmetics manufacturers in March 2019. These inspections were part of the 2019 Cosmetics Supervision Work Plan and were based on the "Key Points for Cosmetic Production License Inspection." Among the facilities inspected were Guilin Gaole Pharmaceutical & Health Products Co., Ltd. (March 21), Guilin Yunhan Daily Chemical Co., Ltd. (March 19), Guilin Xuefulian Daily Chemical Co., Ltd. (March 20), Guilin Xingrun Cosmetics Co., Ltd. (March 20), and Guilin Huanowei Biotechnology Co., Ltd. (March 20).

Key violations and issues identified across these companies included incomplete or missing equipment identification (e.g., shrink film machine, laboratory instruments), absence of essential environmental monitoring devices such as thermometers and hygrometers in critical areas (weighing rooms, changing rooms, refrigerators), and improper storage of raw materials (unsealed items) and laboratory reagents. Operational readiness was also a concern, as some companies, like Guilin Xingrun and Guilin Huanowei, had not fully commenced production since obtaining their licenses. Guilin Xingrun also presented issues with a changing room lacking a differential pressure gauge.

Required actions generally mandated the companies to rectify the identified deficiencies within a specified period and submit a detailed rectification report to the administration. Guilin Xuefulian Daily Chemical Co., Ltd. had already completed its rectifications. Guilin Xingrun Cosmetics Co., Ltd., however, was ordered to undergo a follow-up supervision and inspection by the Drug Administration before officially resuming any production activities to ensure full compliance with regulatory standards.

Company: https://www.globalkeysolutions.net/companies/guilin-gaole-pharmaceutical-and-health-products-co-ltd/7fcdcc08-5ca3-43f2-b041-0e736e0ce410/